Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

HKI-272 for HER2-Positive Breast Cancer and Brain Metastases

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2016 by Dana-Farber Cancer Institute
Sponsor:
Collaborator:
Translational Breast Cancer Research Consortium
Information provided by (Responsible Party):
Rachel Freedman, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01494662
First received: December 14, 2011
Last updated: December 16, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):